Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay

International Journal of Tuberculosis and Lung Disease

Volumn 18, Issue 2, 2014, Pages 227-232

  Trollip, André P ^a   Moore, D ^b,c   Coronel, J ^c   Caviedes, L ^c   Klages, S ^a   Victor, T ^a   Romancenco, E ^d   Crudu, V ^d   Ajbani, K ^e   Vineet, V P ^e   Rodrigues, C ^e   Jackson, R L ^f   Eisenach, K ^g   Garfein, R S ^f   Rodwell, T C ^f   Desmond, E ^h   Groessl, E J ⁱ   Ganiats, T G ⁱ   Catanzaro, A ^f  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^d Microbiology and Morphology Laboratory   (Moldova)

^e P D HINDUJA NATIONAL HOSPITAL   (India)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^h CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aminoglycosides; Drug susceptibility testing; Fluoroquinolones; MODS; Tuberculosis

Indexed keywords

AMIKACIN; CAPREOMYCIN; KANAMYCIN; MOXIFLOXACIN; OFLOXACIN;

ACCURACY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG SCREENING; HIGH RISK PATIENT; HUMAN; INDIA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MICROSCOPIC OBSERVATION DRUG SUSCEPTIBILITY ASSAY; MOLDOVA; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; SOUTH AFRICA; SPUTUM CULTURE;

AMIKACIN; ANTITUBERCULAR AGENTS; CAPREOMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; HUMANS; INDIA; KANAMYCIN; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; MOLDOVA; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; PERU; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SOUTH AFRICA; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84892588702     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0229     Document Type: Article

References (25)

1. Zignol M, van Gemert W, Falzon D, et al. Surveillance of antituberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull World Health Organ 2012; 90: 111-119
2. Falzon D, Jaramillo E, Schünemann H J, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38: 516-528
3. Klopper M, Warren R, Hayes C, et al. Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa. Emerg Infect Dis 2013; 19: 449-455
4. Lin G, Desmond E, Bonato D, et al. Multicenter evaluation of BACTEC MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex. J Clin Microbiol 2009; 47: 3630-3634
5. Rüsch-Gerdes S, Domehl C, Nardi G, et al. Multicenter evaluation of the Mycobacteria Growth Indicator Tube for testing susceptibility of Mycobacterium tuberculosis to fi rst-line drugs. J Clin Microbiol 1999; 37: 45-48
6. Cunningham J A, Winfrey W, Perkins M D. Global survey of tuberculosis laboratory services. Int J Tuberc Lung Dis 2004; 8 (Suppl 1): S178
7. Ling D I, Zwerling A A, Pai M. Rapid diagnosis of drug-resistant TB using line probe assays: from evidence to policy. Expert Rev Respir Med 2008; 2: 583-588
8. Barnard M, Warren R, Van Pittius N G, et al. GenoType MTBDRsl line probe assay shortens time to diagnosis of XDR-TB in a high-throughput diagnostic laboratory. Am J Respir Crit Care Med 2012; 186: 1298-1305
9. Theron G, Peter J, van Zyl-Smit R, et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 2011; 184: 132-140
10. Meyer-Rath G, Schnippel K, Long L, et al. The impact and cost of scaling up GeneXpert MTB/RIF in South Africa. PLOS ONE2012; 7: e36966
11. Caviedes L, Lee T S, Gilman R H, et al. Rapid, effi cient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. J Clin Microbiol 2000; 38: 1203-1208
12. Moore D, Mendoza D, Gilman R, et al. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resourcepoor settings. J Clin Microbiol 2004; 42: 4432-4437
13. Minion J, Leung E, Menzies D, et al. Microscopic observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and metaanalysis. Lancet Infect Dis 2010; 10: 688-698
14. Fitzwater S P, Sechler G A, Jave O, et al. Second-line anti-TB drug concentrations for susceptibility testing in the MODS assay. Eur Respir J 2013; 41: 1163-1171
15. World Health Organization. Policy guidance on drug susceptibility testing of second line anti-tuberculosis drugs. WHO/ HTM/TB/2008.392. Geneva, Switzerland: WHO, 2008
16. Bastian I, Rigouts L, Palomino J C, et al. Kanamycin susceptibility testing of Mycobacterium tuberculosis using Mycobacterium Growth Indicator Tube and a colorimetric method. Antimicrob Agents Chemother 2001; 45: 1934-1936
17. Park W G, Bishai W R, Chaisson R E, et al. Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis. J ClinMicrobiol 2002; 40: 4750-4752
18. World Health Organization. Laboratory biosafety manual. 3rd ed. Geneva, Switzerland: WHO, 2004
19. Kubica G P, Dye W E, Cohn M L, et al. Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria. Am Rev Respir Dis 1963; 87:775-779
20. Moore D, Evans C, Gilman R, et al. Microscopic observation drug susceptibility assay for the diagnosis of TB. N Engl J Med 2007; 355: 1539-1550
21. Ängeby K, Juréen P,Kahlmeter G, et al. Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis. Bull World Health Organ 2012; 90: 693-698
22. Devasia R A, Blackman A, May C, et al. 2009. Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fl uoroquinolone cross-resistance. J Antimicrob Chemother 2009; 63: 1173- 1178
23. Arias M, Mello F, Pavón A, et al. Clinical evaluation of the microscopic observation drug susceptibility assay for detection of tuberculosis. Clin Infect Dis 2007; 44: 674-680
24. Ha D, Lan N, Wolbers M, et al. Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrugresistant tuberculosis in Viet Nam. BMC Infect Dis 2012; 12: 49
25. Siddiqi S, Ahmed A, Asif S, et al. Direct drug susceptibility testing of Mycobacterium tuberculosis for rapid detection of multidrug resistance using the Bactec MGIT 960 system: a multicenter study. J Clin Microbiol 2012; 50: 435-440